OCDX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 08:00):

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide...

Stats
今日成交量	789 491
平均成交量	1.01M
市值	0.00
EPS	$0.0612 ( 2022-05-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-42.28
ATR14	$0.509 (2.89%)

Insider Trading

Date	Person	Action	Amount	type
2022-05-27	Perez David Brian	Sell	8 576	Ordinary Shares, $0.00001 par value
2022-05-27	Hull Carl	Sell	41 172	Ordinary Shares, $0.00001 par value
2022-05-27	Dilsaver Evelyn S	Sell	5 200	Ordinary Shares, $0.00001 par value
2022-05-27	Carlyle Partners Vi Cayman Holdings, L.p.	Sell	118 106 000	Ordinary Shares, $0.00001 par value
2022-05-27	Carlyle Group Inc.	Sell	118 106 000	Ordinary Shares, $0.00001 par value

INSIDER POWER
-100.00
Last 11 transactions
Buy: 10 400 \| Sell: 261 566 948

音量相关性

長: 0.02 (neutral)

短: -0.22 (neutral)

Signal:(49.304) Neutral

Ortho Clinical 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Ortho Clinical 相关性 - 货币/商品

0.11
( neutral )

0.04
( neutral )

-0.26
( neutral )

0.22
( neutral )

0.06
( neutral )

-0.49
( neutral )

Ortho Clinical 财务报表

Annual	2021
营收:	$2.04B
毛利润:	$1.04B (50.71 %)
EPS:	$-0.0382

FY	2021
营收:	$2.04B
毛利润:	$1.04B (50.71 %)
EPS:	$-0.0382

FY	2020
营收:	$1.77B
毛利润:	$858.00M (48.58 %)
EPS:	$-0.978

FY	2019
营收:	$1.80B
毛利润:	$879.10M (48.80 %)
EPS:	$-0.710

Financial Reports:

No articles found.

Ortho Clinical

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.